Digital Health Impact 2020

September 30, 2020 9:30 AM - 2:00 PM

Online Conference, Link will be sent in advance of the event.

Add to Calendar 9/30/2020 9:30:00 AM 9/30/2020 2:00:00 PM Digital Health Impact 2020

The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning, digital technologies are easing data collection from patients, increasing medical adherence, supplementing clinical trials, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes.

Join MassBio for our annual Digital Health Impact 2020 event as we examine the current state of digital health as it relates to the life sciences, the challenges facing its growth, and opportunities for collaboration. Through keynotes, panel discussions, and case studies, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients.

Please contact Laura Rudberg for sponsorship opportunities.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.

 Online Conference, Link will be sent in advance of the event.
Director, Business Development, US Health & Life Sciences, Microsoft
Claire currently serves as Director of Business Development of US Health & Life Sciences with a focus on Life Science and Pharmaceutical companies. She works in partnership with US life science companies, pharma, and health organizations to determine innovative Microsoft solutions specific to the company’s issues affecting their patients and their business. She brings with her an expertise in the clinical trial and pharmaceutical industry, having been a global study lead on oncology clinical trials at a large pharmaceutical company prior to joining Microsoft. Claire earned a Bachelor of Science in Biochemistry from Seattle University and a certification in the Foundations of Clinical Monitoring. She is passionate about the many services and innovations Microsoft has to offer to reduce time to market for new drugs and provide better outcomes to patients. Claire also has a passion for inspiring young women to be interested in STEM and leadership roles in STEM related fields. She recently hosted and spoke at the HBA Seattle Digital Health Panel and is very involved in local mentorship programs for girls in STEM.

Brought to you by